نتائج البحث - Lorinda Simms

  • يعرض 1 - 8 نتائج من 8
تنقيح النتائج
  1. 1
    Biostatistics Primer: What a Clinician Ought to Know—Prognostic and Predictive Factors

    Biostatistics Primer: What a Clinician Ought to Know—Prognostic and Predictive Factors حسب Lorinda Simms, Helen Barraclough, Ramaswamy Govindan

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    The Prognostic and Predictive Role of Histology in Advanced Non-small Cell Lung Cancer: A Literature Review

    The Prognostic and Predictive Role of Histology in Advanced Non-small Cell Lung Cancer: A Literature Review حسب Fred R. Hirsch, Anna Spreafico, Silvia Novello, Mary Dugan Wood, Lorinda Simms, Mauro Papotti

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies

    The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies حسب Giorgio V. Scagliotti, Nasser H. Hanna, Frank V. Fossella, Katherine P. Sugarman, J. Blatter, Patrick Peterson, Lorinda Simms, Frances A. Shepherd

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer

    Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer حسب Giorgio V. Scagliotti, Thomas Brodowicz, Frances A. Shepherd, Christoph Zielinski, Johan Vansteenkiste, Christian Manegold, Lorinda Simms, Frank V. Fossella, Katherine P. Sugarman, Chandra P. Belani

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment

    Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment حسب Kathy S. Albain, Shona Nag, G. Calderillo-Ruiz, Johann Petrus Jordaan, Antonio Llombart–Cussac, A Płużańska, Janusz Rolski, Allen S. Melemed, Jose M. Reyes-Vidal, Jagdev Singh Sekhon, Lorinda Simms, Joyce O’Shaughnessy

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

    Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer حسب Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, U. Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Göksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David R. Gandara

    منشور في 2008
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer

    Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Ca... حسب John R. Mackey, Manuel Ramos-Vázquez, O. N. Lipatov, Nicole McCarthy, Dmitriy Krasnozhon, Semiglazov Vf, Alexey Manikhas, Karen A. Gelmon, Gottfried E. Konecny, Marc Webster, Roberto Hegg, Sunil Verma, Vera Gorbunova, Dany Abi Gerges, Francois Thireau, Helena Fung, Lorinda Simms, Marc Buyse, Ayman Ibrahim, Miguel Martín

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

    Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function حسب Alain C. Mita, Christopher J. Sweeney, Sharyn D. Baker, Andrew Goetz, Lisa A. Hammond, Amita Patnaik, Anthony W. Tolcher, Miguel A. Villalona‐Calero, Alan Sandler, Tuhin K. Chaudhuri, Kathleen Molpus, Jane E. Latz, Lorinda Simms, Ajai K. Chaudhary, Robert D. Johnson, Eric K. Rowinsky, Chris H. Takimoto

    منشور في 2006
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: